Primary scale-up bioreactors containing insect cells for the production of VaxSyn,an experimental AIDS vaccine. VaxSyn is based on a genetically-engineered,recombinant form of the HIV protein gp160,which is a precursor to one of HIV's surface proteins. VaxSyn is genetically- engineered from the baculovirus (an insect virus),with insect cell cultures used in the scale-up process. VaxSyn contains no attenuated infectious parts of HIV & therefore carries no risk of transmitting AIDS. The vaccine is being developed by MicroGeneSys and is undergoing trials as a treatment of HIV-positive patients & as a potential vaccine against HIV infection | |
Licence : | Droits gérés |
Crédit: | Science Photo Library / Morgan, Hank |
Taille de l’image : | 5599 px × 3711 px |
Model Release : | Le droit n'est pas encore disponible. Merci de nous contacter avant utilisation. |
Property Release : | Non requis |
Restrictions : |
|